Rifka C. Schulman-Rosenbaum
Endocrinology
865 Northern Boulevard
Suite 203
Great Neck, NY 11021
Suite 203
Great Neck, NY 11021
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Corrigendum to "American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update" [Endocrine Practice. 2026;32(4):473-518].
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: June 12, 2026
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 17, 2025
American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults With Type 2 Diabetes - 2026 Update.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: November 17, 2025
The Intersection of Diabetes and Eating Disorders: Prevention, Screening, Diagnosis, and Management.
The Intersection of Diabetes and Eating Disorders: Prevention, Screening, Diagnosis, and Management.
Journal: American journal of lifestyle medicine
Published: March 05, 2025
Updates on perioperative cessation of SGLT2 inhibitors.
Journal: British journal of anaesthesia
Published: December 18, 2024
Establishing Screening Programs for Presymptomatic Type 1 Diabetes: Practical Guidance for Diabetes Care Providers.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 16, 2024
Pros and Cons of Inpatient SGLT2i Use for Hyperglycemia and Heart Failure.
Journal: Journal of the Endocrine Society
Published: November 18, 2024
Erratum. Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 2024;47:1276-1298.
Journal: Diabetes care
Published: September 06, 2024
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
Journal: Diabetologia
Published: August 08, 2024
Novel Approach to Continuation of Elective Procedures in People at Risk for Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Ketoacidosis.
Journal: Diabetes spectrum : a publication of the American Diabetes Association
Published: May 17, 2024
Last Updated: 09/26/2026